Palisade Bio (PALI) Prepaid Assets (2010 - 2026)
Palisade Bio (PALI) posted quarterly Prepaid Assets of $615000.0 for Q1 2026, down 6.39% year-over-year from $657000.0 in Q1 2025, and down 26.44% quarter-over-quarter from $836000.0 in Q4 2025.
Powered by 
Analysis
Palisade Bio (PALI) Prepaid Assets (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Prepaid Assets for 17 consecutive years, with $615000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 6.39% year-over-year to $615000.0; the TTM figure through Mar 2026 stood at $615000.0 (down 6.39% YoY), while the FY2025 annual figure was $836000.0, up 24.22% from the prior year.
- Prepaid Assets slipped to $615000.0 in Q1 2026 per PALI's latest filing, from $836000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.4 million in Q4 2022 and bottomed at $5000.0 in Q3 2023.
- Historically, Prepaid Assets has averaged $760500.0 across 5 years, with a median of $717500.0 in 2023.
- Annual changes were most pronounced in 2023 — Prepaid Assets tumbled 99.57% — and 2024, when it soared 16500.0%.
- Palisade Bio's Prepaid Assets stood at $2.4 million in 2022, then slumped by 61.87% to $896000.0 in 2023, then dropped by 24.89% to $673000.0 in 2024, then grew by 24.22% to $836000.0 in 2025, then dropped by 26.44% to $615000.0 in 2026.
- Business Quant data shows PALI's Prepaid Assets at $615000.0 in Q1 2026, $836000.0 in Q4 2025, and $445000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 615,000.00 |
| Dec 31, 2025 | 836,000.00 |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 657,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Sep 30, 2024 | 830,000.00 |
| Jun 30, 2024 | 959,000.00 |
| Mar 31, 2024 | 737,000.00 |
| Dec 31, 2023 | 896,000.00 |
| Sep 30, 2023 | 954,000.00 |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 762,000.00 |
| Dec 31, 2022 | 2.35 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 1.99 Mn |